Digital data transformation: optimizing CGT processes and accelerating scale-up & tech transfer for manufacturing success
Cell & Gene Therapy Insights 2022; 8(8), 773;
DOI: 10.18609/cgti.2022.116
Published: 8 September 2022
FastFacts
- Bridging the data gap between R&D and manufacturing with purpose-built software
- Best practices on using technology to ensure highly complex CGT processes are successfully replicated and controlled
- Establishing reasonable expectations for data visibility and sharing in sponsor/CMO relationships
- Identifying the right time to build a digital data strategy and key IT requirements when choosing a software platform